23andMe administrators surrender because the CEO of the genetic-testing corporate seeks to take it non-public
NEW YORK (AP) — All of 23andMe’s impartial administrators resigned from its board this week, a unprecedented transfer that marks the newest problem for the genetic-testing corporate.The resignations apply drawn-out negotiations with
